Download PDF
Digestive Disease Interventions 2025; 09(02): 086-093
DOI: 10.1055/s-0044-1791773
Review Article

Transjugular Intrahepatic Portosystemic Shunts for Acute and Chronic Portal Vein Thrombosis in Preparation for Liver Transplant

Paula M. Novelli 
1   Division of Interventional Radiology, Department of Radiology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
,
Madeline Leo
2   University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania
,
Philip D. Orons
1   Division of Interventional Radiology, Department of Radiology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Abstract

The presence of portal vein thrombosis (PVT) in the pre-liver transplant patient can significantly impact waitlist, peri- and posttransplant outcomes, morbidity, and mortality. This article describes the pathophysiology of PVT and treatment options in patients with cirrhosis. It defines indications and rationale for placing transjugular intrahepatic portosystemic shunts, emphasizing technical details and risks in patients with nonneoplastic PVT awaiting liver transplantation.

Keywords

portal vein thrombosis - transjugular intrahepatic portosystemic shunt - liver transplant


Publication History

Received: 14 April 2024

Accepted: 09 September 2024

Article published online:
25 November 2024

© 2024. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Ramalingam V, Yang LM, McCarthy CJ, Ahmed M. Interventional approach to portal vein thrombosis and liver transplantation: state of the art. Life (Basel) 2023; 13 (06) 1262
    PubMedSearch in Google Scholar
  • 2 Ponziani ER, Zacco MA, Senzolo M. et al Portal vein thrombosis and liver transplantation. Transplant Rev 2014; 8: 92-101
    CrossrefPubMedSearch in Google Scholar
  • 3 Novelli PM, Tublin JM, Orons PD. Correcting coagulopathy for image-guided procedures. Semin Intervent Radiol 2022; 39 (04) 428-434
    Thieme ConnectPubMedSearch in Google Scholar
  • 4 Francoz C, Belghiti J, Vilgrain V. et al. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation. Gut 2005; 54 (05) 691-697
    CrossrefPubMedSearch in Google Scholar
  • 5 Cho JY, Suh KS, Shin WY, Lee HW, Yi NJ, Lee KU. Thrombosis confined to the portal vein is not a contraindication for living donor liver transplantation. World J Surg 2008; 32 (08) 1731-1737
    CrossrefPubMedSearch in Google Scholar
  • 6 Englesbe MJ, Schaubel DE, Cai S, Guidinger MK, Merion RM. Portal vein thrombosis and liver transplant survival benefit. Liver Transpl 2010; 16 (08) 999-1005
    CrossrefPubMedSearch in Google Scholar
  • 7 DeLeeuw P, Agbim U. Pre-transplant portal vein thrombosis in non-alcoholic fatty liver disease patients-pathogenesis, risk factors, and implications on management. Transl Gastroenterol Hepatol 2022; 7: 27
    CrossrefPubMedSearch in Google Scholar
  • 8 Swan D, Lisman T, Tripodi A, Thachil J. The prothrombotic tendency of metabolic-associated fatty liver disease. J Thromb Haemost 2023; 21 (11) 3045-3055
    CrossrefPubMedSearch in Google Scholar
  • 9 Yerdel MA, Gunson B, Mirza D. et al. Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome. Transplantation 2000; 69 (09) 1873-1881
    CrossrefPubMedSearch in Google Scholar
  • 10 Bozzato AM, Bruno O, Payance A. et al. Portal vein thrombosis: Baveno VII consensus recommendations for diagnosis and management. Radiographics 2023; 43 (11) e230128
    CrossrefPubMedSearch in Google Scholar
  • 11 Werner KT, Sando S, Carey EJ. et al. Portal vein thrombosis in patients with end stage liver disease awaiting liver transplantation: outcome of anticoagulation. Dig Dis Sci 2013; 58 (06) 1776-1780
    CrossrefPubMedSearch in Google Scholar
  • 12 Intagliata NM, Caldwell SH, Tripodi A. Diagnosis, development, and treatment of portal vein thrombosis in patients with and without cirrhosis. Gastroenterology 2019; 156 (06) 1582-1599.e1
    CrossrefPubMedSearch in Google Scholar
  • 13 Basili S, Pastori D, Raparelli V, Violi F. Anticoagulant therapy in patients with liver cirrhosis and portal vein thrombosis: insights for the clinician. Therap Adv Gastroenterol 2018; 11: 1756284818793561
    CrossrefPubMedSearch in Google Scholar
  • 14 Hepatobiliary Disease Study Group, Chinese Society of Gastroenterology, Chinese Medical Association. Consensus for management of portal vein thrombosis in liver cirrhosis (2020, Shanghai). J Dig Dis 2021; 22 (04) 176-186 [ Erratum in: J Dig Dis. 2021 May;22(5):295. PMID: 33470535; PMCID: PMC8252415]
    CrossrefPubMedSearch in Google Scholar
  • 15 Qi X, De Stefano V, Li H, Dai J, Guo X, Fan D. Anticoagulation for the treatment of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis of observational studies. Eur J Intern Med 2015; 26 (01) 23-29
    CrossrefPubMedSearch in Google Scholar
  • 16 Loffredo L, Pastori D, Farcomeni A, Violi F. Effects of anticoagulants in patients with cirrhosis and portal vein thrombosis: a systematic review and meta-analysis. Gastroenterology 2017; 153 (02) 480-487.e1
    CrossrefPubMedSearch in Google Scholar
  • 17 Guerrero A, Campo LD, Piscaglia F. et al; Baveno Cooperation: An EASL Consortium. Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: the IMPORTAL competing-risk meta-analysis. J Hepatol 2023; 79 (01) 69-78
    CrossrefPubMedSearch in Google Scholar
  • 18 Mui B, Grinspan L, Crismale J. Variations in practice among cirrhotic patients with portal vein thrombosis and esophageal varices: a North American survey study. Am J Gastroenterol 2024; 119 (04) 774-777
    PubMedSearch in Google Scholar
  • 19 European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu. Vascular diseases of the liver. J Hepatol 2016; 64 (01) 179-202
    CrossrefPubMedSearch in Google Scholar
  • 20 Simonetto DA, Singal AK, Garcia-Tsao G, Caldwell SH, Ahn J, Kamath PS. ACG clinical guideline: disorders of the hepatic and mesenteric circulation. Am J Gastroenterol 2020; 115 (01) 18-40
    CrossrefPubMedSearch in Google Scholar
  • 21 de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C. Baveno VII Faculty. Baveno VII - renewing consensus in portal hypertension. J Hepatol 2022; 76 (04) 959-974
    CrossrefPubMedSearch in Google Scholar
  • 22 Agbim U, Satapathy SK. PRO: portal vein thrombosis impacts liver transplantation outcomes. Clin Liver Dis (Hoboken) 2020; 16 (04) 127-131
    CrossrefPubMedSearch in Google Scholar
  • 23 Rizzari MD, Safwan M, Sobolic M. et al. The impact of portal vein thrombosis on liver transplant outcomes: Does grade or flow rate matter?. Transplantation 2021; 105 (02) 363-371
    CrossrefPubMedSearch in Google Scholar
  • 24 Radosevich PM, Ring EJ, LaBerge JM. et al. Transjugular intrahepatic portosystemic shunts in patients with portal vein occlusion. Radiology 1993; 186 (02) 523-527
    CrossrefPubMedSearch in Google Scholar
  • 25 Lv Y, Bai W, Li K. et al. Anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis: a prospective observational study. Am J Gastroenterol 2021; 116 (07) 1447-1464 [Erratum in Am. J. Gastroenterol. 2022, 117, 200]
    CrossrefPubMedSearch in Google Scholar
  • 26 Lee EW, Eghtesad B, Garcia-Tsao G. et al. AASLD Practice Guidance on the use of TIPS, variceal embolization, and retrograde transvenous obliteration in the management of variceal hemorrhage. Hepatology 2024; 79 (01) 224-250 I
    CrossrefPubMedSearch in Google Scholar
  • 27 Entezari P, Riaz A, Thornburg B, Salem R. Percutaneous ultrasound-guided superior and inferior mesenteric vein access for portal vein recanalization-transjugular intrahepatic portosystemic shunt: a case series. Cardiovasc Intervent Radiol 2021; 44 (03) 496-499
    CrossrefPubMedSearch in Google Scholar
  • 28 Thornburg B, Desai K, Hickey R. et al. Pretransplantation portal vein recanalization and transjugular intrahepatic portosystemic shunt creation for chronic portal vein thrombosis: final analysis of a 61-patient cohort. J Vasc Interv Radiol 2017; 28 (12) 1714-1721.e2
    CrossrefPubMedSearch in Google Scholar
  • 29 Talwar A, Varghese J, Knight GM. et al. Preoperative portal vein recanalization-transjugular intrahepatic portosystemic shunt for chronic obliterative portal vein thrombosis: outcomes following liver transplantation. Hepatol Commun 2022; 6 (07) 1803-1812
    CrossrefPubMedSearch in Google Scholar